$CW

Curtiss-Wright Expands 2026 Share Repurchase Authorization

Curtiss-Wright (CW) said it expanded its 2026 share repurchase authorization by adding a Rule 10b5-1 plan that allocates an additional $100 million for buybacks. The company expects total 2026 repurchases of $160 million and said $390 million remains authorized. It plans broker purchases up to Rule 10b-18 limits until the $100 million is deployed, expected by late August 2026.

Original reporting
Published Aug 12, 2026, 3:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 5:13 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Curtiss-Wright Expands 2026 Share Repurchase Authorization — source image
Decision brief

The 30-second read

$CWBullishMed
01

Why it matters

The company states the expanded plan is intended to signal confidence in its upgraded 2026 outlook, supported by strong free cash flow and balance sheet strength, while maintaining flexibility for strategic acquisitions.

02

Market read

This is a concrete capital allocation update with a defined incremental buyback amount and execution window, which can influence near-term sentiment and positioning.

03

What to watch

Traders should monitor whether the company’s “upgraded 2026 outlook” is later quantified in guidance or filings, and whether free cash flow supports the full $160M repurchase expectation.

Relevance 7/10Novelty 6/10Timing: within the month, with $100M buybacks expected to be fully deployed by end-August 2026

Background

Curtiss-Wright previously authorized buybacks in 2026 and is now adding a new Rule 10b5-1 trading plan tied to that authorization.

Company-level read

Ticker impact

$CWBullishMedium confidence
Context

Curtiss-Wright expanded its 2026 buyback by adding a $100 million Rule 10b5-1 plan, targeting full deployment by end-August 2026.

Expected impact

Modestly positive bias for the stock over days to weeks, with follow-through tied to execution and any subsequent SEC buyback disclosures.

Evidence & confidence

A larger, time-bound repurchase tranche is a concrete capital allocation update, but it is not a new earnings or guidance print and buybacks are typically gradual under 10b5-1.

Market effects

Defense and aerospace peers may be watched for similar capital return moves, but this is company-specific rather than a sector reset.

Limited direct regional impact; primarily affects US-listed defense industrial sentiment.

Low global relevance beyond defense industrial capital allocation signaling.

Counterpoint

Buyback expansion can also reflect limited near-term organic investment opportunities, so it may not imply upside to fundamentals beyond capital return.

Key entities

  • Curtiss-Wright Corporation

    Expanded 2026 share repurchase authorization by $100 million via a Rule 10b5-1 plan, targeting completion by end-August 2026.

Related articles

$CWMedAI 8/10

DOE Backs X-Energy Texas Reactor Project With $1 Billion Support

The U.S. Department of Energy (DOE) allocated up to $1 billion to support X-Energy's advanced nuclear reactor project in Texas. Funds will primarily support domestic supply chain partners like Curtiss-Wright, Mirion Technologies, and Fluor. The Range Nuclear Renaissance Index ETF (NUKZ) offers investors exposure to these companies.

$CWHighAI 9/10

Curtiss-Wright (CW) Q2 2026 Earnings Call Transcript

Curtiss-Wright (CW) reported Q2 2026 adjusted diluted EPS of $3.72, up 15% year over year, on total sales of $924 million, up 5%. New orders were $1.1 billion, up 8%, with a 1.16x book-to-bill. Management raised full-year sales guidance to 8% to 9% and adjusted EPS to $15.10 to $15.40, and lifted free cash flow guidance to $585 million to $605 million.

$CWHighAI 9/10

Curtiss-Wright Q2 Earnings Call Highlights

Curtiss-Wright (NYSE:CW) reported Q2 commentary from its earnings call, citing a strengthening order book tied to U.S. and international defense spending and momentum in commercial aerospace and industrial markets. Defense Electronics sales fell 3% while Aerospace & Industrial and Naval & Power rose. The company raised 2026 guidance: sales +8% to +9%, operating margin 19.1% to 19.3%, diluted EPS $15.10 to $15.40, and record free cash flow $585M to $605M.

$CWMed

Curtiss-Wright Slides as Investors Weigh Strong Q2 Against Rich Expectations

Curtiss-Wright (CW) shares fell about 3.2% as investors weighed a strong Q2 against expectations. The company reported Q2 2026 sales of $924 million (+5%), adjusted operating margin of 19.4%, and adjusted EPS of $3.72, while raising full-year guidance to sales growth of 8% to 9% and adjusted EPS of $15.10 to $15.40. Orders were $1.1 billion (1.16 book-to-bill), but Defense Electronics revenue declined and Ground Defense fell 8% due to timing.

$CWHigh

CURTISS WRIGHT CORP (CW): Results of Operations and Financial Condition

CURTISS WRIGHT CORP (CW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991_cwxq226xearnings.htm EX-99.1 Document Curtiss-Wright Corporation, Page 1 Exhibit 99.1 NEWS RELEASE CURTISS-WRIGHT REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE DAVIDSON, N.C. – August 5, 2026 – Curtiss-Wright Corporation (NYSE: C